Diabetes, Study | search
Click here to view Diabetes, Study news from 60+ newspapers.
Bookmark or Share- Researchers use AI to help predict and identify subtypes of Type 2 ...This study was funded by The National Institutes of Health (grants R01 DK110186-01, U01-DK105535, U01-DK085545, UM1DK126185 and 2T32HL09804911), the Stanford PHIND center, the Stanford Diabetes Research Center, the Wellcome Trust, Stanford Lifestyle Medicine and the American Diabetes Association.
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 DiabetesTirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist that is under development for the treatment of type 2 diabetes. The...
- New Research Sheds Light on Cause of Type 2 DiabetesThe new study shows that the beta-cells of Type 2 diabetes patients are deficient in a cell trafficking protein called “phosphatidylinositol transfer protein alpha” (or PITPNA), which can promote the formation of “little packages,” or intracellular granules containing insulin.
- Clinical Trials - American Diabetes AssociationDiscover the latest clinical trials and resources for new treatments provided by the American Diabetes Association. Find hope for diabetes and other conditions.
- Flagship AI-ready dataset released in type 2 diabetes studyResearchers today are releasing the flagship dataset from an ambitious study of biomarkers and environmental factors that might influence the development of type 2 diabetes.
More
